4 free views remaining today

non-syndromic X-linked intellectual disability 50

Description

Non-syndromic X-linked intellectual disability (NS-XLMR) refers to a condition where males have intellectual disability without any additional physical, neurological, or psychiatric symptoms. This type of intellectual disability is caused by mutations in genes located on the X-chromosome.

According to various sources [4][5][10], NS-XLMR can be caused by mutations in approximately 40 genes known to cause non-syndromic intellectual disability, with around 80% of these genes residing on the X-chromosome. The prevalence and inheritance pattern of NS-XLMR vary depending on the specific gene involved.

Some characteristics of NS-XLMR include:

  • Intellectual disability is the only symptom
  • Males are more heavily affected than females
  • Females with one affected X chromosome and one normal X chromosome tend to have milder symptoms

It's worth noting that while there are approximately 40 genes known to cause NS-ID, not all of them have been identified or characterized. Further research is needed to fully understand the genetic basis of NS-XLMR.

References: [4] - Non-syndromic X-linked intellectual disability (MRX) belong to the family of sex-linked intellectual deficiencies (XLMR). In contrast to syndromic or specific X-linked intellectual deficiencies (MRXS), which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only symptom of MRX. [5] - Non-syndromic X-linked intellectual disability 14 is characterized by moderate intellectual disability and impaired speech. It is caused by a mutation in a ... [10] - The X-chromosome has historically been the most thoroughly studied chromosome with regard to NS-ID due to the high male to female ratio. There are approximately 40 genes known to cause NS-ID, and ~80% of these reside on the X-chromosome.

Additional Characteristics

  • Males have intellectual disability without any additional physical, neurological, or psychiatric symptoms
  • Includes mutations in approximately 40 genes known to cause non-syndromic intellectual disability
  • Males are more heavily affected than females
  • Females with one affected X chromosome and one normal X chromosome tend to have milder symptoms
  • Prevalence and inheritance pattern vary depending on the specific gene involved

Signs and Symptoms

Non-syndromic X-linked intellectual disability (NS-XLMR) is a condition characterized by intellectual disability in the absence of other symptoms or signs. The signs and symptoms of NS-XLMR can vary from person to person, but some common features include:

  • Intellectual disability: This is the primary symptom of NS-XLMR, with affected individuals typically having an IQ below 70.
  • Weak muscle tone (hypotonia): Many people with NS-XLMR have weak muscle tone, which can delay motor skills such as sitting, standing, and walking [8].
  • Delayed speech development: Affected individuals may experience delayed or absent speech development [7].
  • Average head circumference: Unlike some other forms of intellectual disability, people with NS-XLMR typically have average head circumferences [7].

It's worth noting that not everyone with NS-XLMR will exhibit all of these symptoms, and the severity can vary widely from person to person. Additionally, some individuals may experience additional symptoms or signs, such as:

  • Abnormalities of the eye: Some people with NS-XLMR may have strabismus (crossed eyes) [4].
  • Abnormality of head or neck: Bifid uvula and high palate are also possible features in some cases [4].

It's essential to remember that each individual with NS-XLMR is unique, and the specific signs and symptoms can vary widely. A comprehensive medical evaluation by a qualified healthcare professional is necessary for an accurate diagnosis.

References: [4] - Abnormality of head or neck [7] - Delayed speech development [8] - Weak muscle tone (hypotonia)

Diagnostic Tests

Based on the provided context, it appears that diagnostic tests for non-syndromic X-linked intellectual disability (XLID) have evolved over time.

  • Chromosomal Microarray Analysis (CMA): The medical genetics groups now recommend CMA as a first-line genetic test to identify genetic mutations in children with XLID [5]. This test can help diagnose the specific type of intellectual disability present and guide treatment.
  • Genetic Testing: Genetic testing can also be used to diagnose non-syndromic X-linked intellectual disability. This type of testing can help identify the underlying genetic mutation causing the condition [9].
  • X-chromosome Analysis: Since the discovery of the FMR1 gene in 1991, more than 141 genes have been identified on the X-chromosome that are associated with XLID [10]. Analyzing these genes can provide valuable information for diagnosis and treatment.

It's worth noting that non-syndromic X-linked intellectual disability is a complex condition, and diagnostic tests may not always be able to identify the underlying cause. However, advances in genetic testing have improved our ability to diagnose and understand this condition.

References: [5] - Chromosomal microarray analysis (CMA) as a first-line genetic test for children with XLID. [9] - Genetic testing for non-syndromic X-linked intellectual disability. [10] - Identification of 141 genes on the X-chromosome associated with XLID.

Treatment

Non-syndromic X-linked intellectual disability (XLID) refers to a group of genetic disorders that result in intellectual disability, primarily affecting males due to their single X chromosome. While there is no specific pharmacologic treatment available for cognitive impairment in individuals with XLID, various medications may be prescribed to manage associated symptoms such as seizures and behavioral disturbances.

  • Seizures: Anticonvulsant medication is often necessary to control seizures in patients with XLID [8].
  • Behavioral disturbances: Medication may also be required to address behavioral issues that can accompany intellectual disability [8].

However, it's essential to note that the primary goal of treatment for individuals with XLID is to manage associated symptoms and improve quality of life, rather than directly addressing cognitive impairment.

According to a review on the genetic basis of non-syndromic intellectual disability, there are currently no specific pharmacologic treatments available for cognitive impairment in individuals with XLID [12]. The authors suggest that further research is needed to explore potential therapeutic options for this condition.

In summary, while there is no direct drug treatment for non-syndromic X-linked intellectual disability, various medications may be prescribed to manage associated symptoms such as seizures and behavioral disturbances.

Recommended Medications

  • Seizures
  • Behavioral disturbances

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6539
owl#annotatedSource
t383902
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112029
core#notation
DOID:0112029
oboInOwl#hasDbXref
MIM:300115
IAO_0000115
A non-syndromic X-linked intellectual disability characterized by moderate intellectual disability that has_material_basis_in mutation in a region on chromosome Xp11.3-p11.21.
oboInOwl#hasExactSynonym
XLID50
rdf-schema#label
non-syndromic X-linked intellectual disability 50
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050776
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.